Flagyl I.V.

   
Google
 
Web NewDrugInformation.com

Flagyl I.V.


Drug - Flagyl I.V.
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Metronidazole Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE/VIAL
The potency of the active ingredient(s), Metronidazole Hydrochloride. May repeat for multiple part products.

Applicant - GD SEARLE LLC
The firm name holding legal responsibility for Flagyl I.V.. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018353
The FDA assigned number to Flagyl I.V.. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Flagyl I.V.. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Flagyl I.V. was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Flagyl I.V.. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Flagyl I.V. is in. Format is RX, OTC, DISCN.

Applicant Full Name - Gd Searle Llc
The full name of the firm holding legal responsibility for the new application of Flagyl I.V..

Flagyl I.V.